U.S. Healthcare Services Stock News

Independent Bank (INDB) is back in focus after its second quarter update, as investors weigh a smaller pool of net charge offs and fresh details on the company’s recent share repurchase activity. See our latest analysis for Independent Bank. The Q2 results initially triggered a sharp negative reaction, with Independent Bank shares sliding after the earnings miss. The stock still shows a 30 day share price return of 4.24% and a 1 year total shareholder return of 25.64%, suggesting longer term...

With inflation cooling but still above target in many regions and energy markets influenced by geopolitical tensions, investors are looking for leaders who are directly aligned with shareholders. Founder led companies often have higher capital efficiency and meaningful personal stakes, which can be appealing when growth signals are mixed across the United States, Europe, Latin America and Asia-Pacific. This Top Founder-Led Companies screener focuses on businesses where the original builder is...

Earlier this month, Kaplan Fox & Kilsheimer LLP began investigating Alignment Healthcare after a former executive alleged accounting irregularities, including misclassifying millions of dollars of operating expenses as capital expenditures and inflating key metrics such as Adjusted EBITDA. The whistleblower-driven probe raises questions about the reliability of previously reported financial metrics that underpinned market confidence in Alignment Healthcare’s performance and efficiency. Now...

ADMIRE Milestone and Why It Matters for Alpha Tau Medical Stock Alpha Tau Medical (NasdaqCM:DRTS) drew fresh attention after reporting the first successful treatment of an immunocompromised patient in its ADMIRE clinical study for recurrent cutaneous squamous cell carcinoma using Alpha DaRT. This marks a key clinical milestone for a vulnerable cancer population that often has limited treatment options, giving investors new information to weigh around the company’s technology focus and...

In July 2026, Nextpower Inc. asked stockholders to approve amendments to its Second Amended and Restated Certificate of Incorporation, including removing legacy Class B common stock, eliminating outdated provisions, and renaming its Class A common stock at the August 18, 2026 annual meeting. This clean‑up of the capital structure highlights management’s focus on simplifying the equity base, which can matter for governance, liquidity, and long‑term investor appeal. Next, we’ll examine how...

In late June 2026, Strategy Inc. restructured its finance leadership as Chief Accounting Officer Jeanine Montgomery retired and CFO Andrew Kang assumed the role of principal accounting officer, while the company pivoted from relentless Bitcoin accumulation to a new framework for selling BTC and building a US$3.00 billion cash reserve. This shift away from a "never sell" posture toward a Bitcoin Monetization Program, aimed at funding preferred dividends and supporting its capital structure,...

In May 2026, Boston Scientific voluntarily began recalling multiple CRE and CRE Pro Wireguided endoscopy devices worldwide, after identifying potential sterile breaches in the packaging of tens of thousands of Class II–classified units, with the US FDA now listing the recalls as ongoing. The concentration of recalls across several size ranges of the same product family highlights how a single packaging issue can ripple through Boston Scientific’s global supply chain, regulatory workload, and...

QuinStreet (QNST) has drawn investor attention after recent share price moves, with the stock now around $16.78 and showing mixed short term performance, alongside stronger returns over the past month and past three months. See our latest analysis for QuinStreet. Recent trading in QuinStreet points to building momentum, with a 30 day share price return of 31.4% and a year to date share price return of 19.18%, set against a 3 year total shareholder return of 86.44% and a 5 year total...

Brady (BRC) stock is drawing fresh attention after distributor Heilind Electronics announced the availability of the Brady i4311 Industrial Label Printer, a portable unit that combines cordless operation with benchtop-style performance for industrial identification tasks. See our latest analysis for Brady. At a share price of $93.69, Brady has seen a 12.27% 1 month share price return and a 19.12% year to date share price return. Its 1 year total shareholder return of 37.39% and 3 year total...

AI related stocks are drawing much of the market’s attention right now, which can leave solid, profitable companies trading on valuations that still look reasonable. That is exactly where a Growth at a Reasonable Price approach can help you focus on businesses with positive earnings profiles and measured risk, without chasing the most crowded trades. This article looks at how the current AI driven rotation interacts with fundamental metrics like P/E and PEG ratios, and highlights three stocks...

Rising geopolitical tensions, questions around US policy, and heavy use of monetary and fiscal stimulus are pushing many investors toward large cap US stocks that look reasonably priced and pay dividends. Instead of chasing the AI boom or trying to guess the next hot trend, this article focuses on value oriented blue chips that may hold up when sentiment swings. Using a US Large Cap Value Stocks screener built around the latest macro shocks, the sections that follow highlight 3 stocks that...

Graco (GGG) has drawn investor attention after recent share performance, with the stock down about 2% over the past day and about 14% over the past 3 months, prompting closer scrutiny of its fundamentals. See our latest analysis for Graco. Looking beyond the latest move, Graco’s share price has slipped over the past quarter and year to date, and the 1 year total shareholder return is also down. This points to fading momentum and a more cautious stance from investors. If you are reassessing...

Booz Allen Hamilton Holding stock has had a tough run over the last few years, yet the valuation checks currently lean in the other direction and suggest the shares may be pricing in a lot of bad news already. With the price at US$65.21 and the broader metrics screening the company as relatively cheap, investors are weighing whether the recent share price weakness has gone too far. The stock is down about 40.3% over the past 3 years, which points to a period where sentiment has been weak...

Earlier this month, Clover Health Investments reported that a hacker used social engineering to access three non-managerial employee accounts on July 4, exposing some personal and protected health information but not its core financial or claims systems. The incident highlights how frontline operational roles, such as visit schedulers and broker-facing staff, can become critical entry points for attackers seeking sensitive member data. We’ll now examine how this cybersecurity breach,...

Cigna Group has delivered a 32.5% gain over the past five years, yet with the stock recently closing at US$281.45, the valuation checks still point to the shares looking inexpensive rather than fully priced in. Over five years, Cigna Group is up 32.5%, which is a steady outcome that does not on its own suggest the stock has been bid up aggressively. The company’s long term valuation can be shaped by how reliably it converts revenue into cash and how effectively it manages healthcare cost...

First Commonwealth Financial stock has quietly put up an 88.2% total return over the past five years. Today the Excess Returns intrinsic value estimate still points to meaningful upside relative to the current US$21.12 share price, even as market based valuation checks suggest the stock is only roughly in line with peers. Over five years, a total return of 88.2% puts First Commonwealth Financial in the category of a steadily compounding bank stock, rather than a short term momentum...

International Paper (IP) is back in focus after confirming the permanent closure of its Carrollton South packaging facility in Texas by the end of Q3 2026. The move affects 64 employees and reinforces its broader restructuring story. See our latest analysis for International Paper. International Paper’s share price has been under pressure, with the stock down 6.68% year to date, while a 3.87% 1 month share price return and 34.90% 3 year total shareholder return suggest longer term sentiment...

In recent weeks, MercadoLibre has drawn attention for combining strong growth, deeper customer engagement, and heavy investments across e-commerce, fintech, logistics, and artificial intelligence, while analysts highlight continued revenue expansion alongside a near-term earnings dip. An investor who put US$1,000 into MercadoLibre in July 2016 would now hold a stake worth about US$12,414.56, underscoring how its integrated logistics and digital banking capabilities have reshaped its role in...

Kontoor Brands (KTB) is back in focus after Lee introduced its LQD Denim collection in the US and Europe, alongside Wrangler’s Toughlite jeans, highlighting fresh product launches that could matter for how investors view the stock. See our latest analysis for Kontoor Brands. Against this backdrop of new product launches, Kontoor Brands’ share price has had a strong run, with a 30 day share price return of 13.99% and a year to date share price return of 39.14%. The 3 year total shareholder...

Earlier this year, Douglas Dynamics reported a strong first quarter, with revenue rising 19.8% year on year and earnings and EBITDA coming in above analyst estimates, prompting management to raise full-year guidance on the back of higher snowfall-driven demand and disciplined execution. An interesting aspect of this update is that Douglas Dynamics now has the highest full-year guidance in its peer group, underlining management’s confidence despite an evolving macroeconomic backdrop. We’ll...

In the past week, Johnson & Johnson reported second-quarter 2026 results showing sales of US$25.31 billion and net income of US$5.53 billion, raised its full-year 2026 sales outlook to between US$100.8 billion and US$101.4 billion, affirmed a third-quarter dividend of US$1.34 per share, and received U.S. FDA approval for its dual-energy THERMOCOOL SMARTTOUCH SF ablation platform. These updates highlight a company balancing growing Innovative Medicine revenues and continued dividend increases...

Earlier this year, Tandem Diabetes Care reported Q1 revenue of US$247.2 million, up 5.5% year on year and ahead of analyst expectations, while also beating earnings estimates and reaffirming full-year revenue guidance. Despite these operational gains, the results also drew attention to Tandem’s continuing lack of profitability and weakening returns on capital, raising questions about how effectively past growth investments are paying off. We’ll now examine how Tandem’s strong Q1 revenue beat...

ICON stock has become a valuation puzzle, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to roughly 31.7% upside while earnings based multiples make the shares look expensive and the three year return remains deeply negative. ICON shareholders have seen the stock decline about 30.9% over the past three years, which puts recent short term gains into the context of a still weak longer term track record. The internal accounting investigation and earnings delay have added a...

Gorilla Technology Group (GRRR) has drawn fresh attention after announcing a private placement of $125 million in 7.50% senior unsecured convertible notes, aimed at funding its NeutraDC Batam data center project in Indonesia. See our latest analysis for Gorilla Technology Group. The NeutraDC Batam financing news lands at a tense moment for Gorilla Technology Group, with the stock’s 7 day share price return down 32.92% and its 1 year total shareholder return declining 36.76%, even as a 4.88% 1...